Alex Fässler
Patrimonio netto: 3 M $ in data 31/08/2026
Patrimonio netto: 3 M $ in data 31/08/2026
Alex Fässler is currently the Head of Operations at Targimmune Therapeutics AG.
Previously, he worked as the Chief Operating Officer at Bachem Holding AG and as the Head of Production & Site Manager at Bachem AG.
He holds a doctorate degree from the Swiss Federal Institute of Technology.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 31/12/2025 | 33.580 ( 0,04% ) | 3 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Direttore operativo | - |
| Società | Posizione | Fine |
|---|---|---|
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Corporate Officer/Principal | - |
| BACHEM HOLDING AG | Direttore operativo | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Bachem Holding AG
Bachem Holding AG Pharmaceuticals: MajorHealth Technology Operates as an independent, technology-based, public biochemical company | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bachem AG
Bachem AG Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals, biochemicals, and related chemical products | Health Technology |
Targimmune Therapeutics AG
Targimmune Therapeutics AG BiotechnologyHealth Technology Develops novel targeted oncology immunotherapies | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale